Medical specialists from France tagged as investigators in clinical trials studying Infections

Total 360 results

Agnès Lefort, MD, PhD
Seen in:
- Strasbourg, Service des Maladies Infectieuses et Tropicales - Hôpitaux Universitaires de Strasbourg
Trials:
- NCT05150327 (Principal Investigator)
Conditions:
- Fungal Infection
Agnès Villemant Ululag
Seen in:
- Clichy, Hôpital Beaujon - Service de médecine interne
Trials:
- NCT05300035 (Principal Investigator)
Conditions:
- HIV/AIDS and Infections
alain BEREBI, MD
Seen in:
- Montpellier, CHU Montpellier
Trials:
- NCT00894257 (Principal Investigator)
Conditions:
Albert Sotto, MD
Seen in:
- Nîmes, CHU de Nimes
Trials:
- NCT03964571 (Sub-Investigator)
Conditions:
- Diabetic Foot Infection
Alexandre GANEA, MD
Seen in:
- Orléans, Department of hemodialysis, University Hospital of Tours
Trials:
- NCT06093269 (Principal Investigator)
Conditions:
- Infection, Bacterial;
- Hemodialysis Catheter Infection
Alia BARTHEL, MD
Seen in:
- Strasbourg, ervice de Chirurgie Orthopédique Septique - CHU de Strasbourg - France
Trials:
- NCT05867108 (Principal Investigator)
Conditions:
- Prosthesis Related Infection
ALICE LAPLANTE
Seen in:
- Paris, 25 Rue de Fécamp
Trials:
- NCT03540706 (Principal Investigator)
Conditions:
- Respiratory Infections in Children;
- Respiratory Infection
André BOIBIEUX
Seen in:
- Lyon, Hospices Civiles de Lyon
- Lyon, Hospices Civils de Lyon
Trials:
- NCT04452487 (Sub-Investigator)
- NCT04603313 (Principal Investigator)
Conditions:
andreas stein
Seen in:
- Marseille, Assistance Publique Hopitaux de Marseille
Trials:
- NCT01957228 (Principal Investigator)
Conditions:
- Prosthetic Joint Infections
Anne Simon, MD
Seen in:
- Paris, Hôpital Pitié-Salpétrière
Trials:
- NCT04597424 (Principal Investigator)
Conditions:
- Risk-Taking;
- Unsafe Sex
Anne Thiebaut
Seen in:
- Isere, Grenoble, CHU de Grenoble - Hôpital Albert Michallon
Trials:
- NCT03583164 (Principal Investigator)
Conditions:
- Invasive Fungal Infections
Anne-Marie Guedj, MD
Seen in:
- Nîmes, CHU de Nimes
- Nîmes, Chu Nimes
Trials:
- NCT03964571 (Sub-Investigator)
- NCT03636243 (Sub-Investigator)
Conditions:
Annie Sobaszek, MD,PhD
Seen in:
- Lille, Hôpital Claude Huriez, CHU
Trials:
- NCT04362267 (Principal Investigator)
Conditions:
- Sars-CoV2
Antoine Avignon, MD
Seen in:
- Montpellier, CHU de Montpellier
Trials:
- NCT03964571 (Sub-Investigator)
Conditions:
- Diabetic Foot Infection
Antoine THIERRY, PhD
Seen in:
- Poitiers, CHU de Poitiers
Trials:
- NCT03211026 (Principal Investigator)
Conditions:
- Kidney Transplantation
Antonin Lamazière
Seen in:
- Paris, Hôpital Necker-Enfants Malades
Trials:
- NCT06228352 (Sub-Investigator)
Conditions:
- Ulcerative Colitis
Antonio Alvarez Gonzalez, MD
Seen in:
- Saint Denis, Delafontaine Hospital
Trials:
- NCT00698919 (Principal Investigator)
Conditions:
- Sepsis;
- Infection
Ariane Sultan, MD
Seen in:
- Montpellier, CHU de Montpellier
Trials:
- NCT03964571 (Principal Investigator)
Conditions:
- Diabetic Foot Infection
Arnaud HOT
Seen in:
- Lyon, Hospices Civiles de Lyon
Trials:
- NCT04452487 (Sub-Investigator)
Conditions:
Aurélie PORTEFAIX, MD,PhD
Seen in:
- Bron, Hôpital Louis Pradel
Trials:
- NCT04376476 (Principal Investigator)
Conditions:
- Severe Acute Respiratory Syndrome Coronavirus 2;
- Infection, Coronavirus
Aurélie SELLAM
Seen in:
- Saint-Maur-des-Fossés, Cabinet du Dr Cohen
Trials:
- NCT03825874 (Sub-Investigator)
Conditions:
- Urinary Tract Infections;
- Urinary Tract Infections in Children
Aurélie VELAY, MD
Seen in:
- Strasbourg, Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
- Strasbourg, Service de Virologie - Hôpital Civil
Trials:
- NCT04405726 (Sub-Investigator)
- NCT05618275 (Sub-Investigator)
Conditions:
- SARS-CoV-2;
- BK Virus Infection
Axel URSENBACH, MD
Seen in:
- Strasbourg, Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Trials:
- NCT05535751 (Principal Investigator)
Conditions:
- Bacteremia
Baptiste HOELLINGER, MD
Seen in:
- Strasbourg, Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Trials:
- NCT05544682 (Sub-Investigator)
- NCT05905380 (Sub-Investigator)
Conditions:
- Multidrug Resistant Bacterial Infection;
- COVID-19 Convalescent Plasma Treatment
Baptiste MICHARD, MD
Seen in:
- Strasbourg, Service deChirurgie Générale Hépatique-Endocrinienne,et transplantation - Hôpitaux Universitaires de Strasbourg
- Strasbourg, Service des Maladies Infectieuses et Tropicales - Hôpitaux Universitaires de Strasbourg
Trials:
- NCT05150327 (Sub-Investigator)
- NCT05079165 (Sub-Investigator)
Conditions:
- Fungal Infection;
- COVID-19
barbara SEITZ POLSKI
Seen in:
- Nice, Nice hospital
- Nice, University Nice Hospital
Trials:
- NCT04174066 (Principal Investigator)
- NCT04429594 (Principal Investigator)
Conditions:
- Nephrotic Syndrome;
- Coronavirus Infections
Bastien GREGOIRE, MD
Seen in:
- Bron, Hospices Civils de Lyon
Trials:
- NCT03112356 (Principal Investigator)
Conditions:
- Endocarditis
Bendedicte Neven, Prof.
Seen in:
- Paris, Hôpital Necker - Enfants Malades
Trials:
- NCT04832607 (Principal Investigator)
Conditions:
Bénédicte Bruno, Dr.
Seen in:
- Lille, Hôpital Jeanne de Flandre, CHU Lille
Trials:
- NCT04832607 (Principal Investigator)
Conditions:

Clinical Trials on Infections

International Centre for Diarrhoeal Disease Research...
Centers for Disease Control and Prevention

Not yet recruiting

Co-administration Study of OCV, TCV and MR

Measles | Rubella | Cholera | Typhoid
MJM Bonten
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1) (EXPECT-1)

E.Coli Infections

United States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
Pfizer

Completed

Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants

Group B Streptococcus Infections

United States, South Africa, United Kingdom
GlaxoSmithKline

Active, not recruiting

A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants

Infections, Meningococcal

Finland, Poland, Spain, United Kingdom, Germany, South Africa, Dominican Republic, Israel, Honduras
Pfizer

Completed

Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine

Infections, Meningococcal

Australia, Canada, Czechia, Panama, South Africa, Turkey
GlaxoSmithKline

Completed

Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children

Infections, Meningococcal

Finland
Pfizer

Completed

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Infections, Meningococcal

Philippines
GlaxoSmithKline

Completed

Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

Infections, Meningococcal

United States, Finland, Poland
Pfizer

Completed

The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination

Infections, Meningococcal

Finland
GlaxoSmithKline

Completed

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Infections, Meningococcal

Australia

Medical specialists from France tagged as investigators in clinical trials studying Infections

Clinical Trials on Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations